Dolby Laboratories (NYSE:DLB – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $95.75.
Several analysts recently issued reports on the company. Barrington Research reissued an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, September 12th. Robert W. Baird assumed coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Baird R W raised Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Rosenblatt Securities reissued a “buy” rating and set a $95.00 target price on shares of Dolby Laboratories in a research note on Friday, August 1st. Finally, Tigress Financial raised their price target on Dolby Laboratories from $112.00 to $114.00 and gave the company a “buy” rating in a report on Friday, August 15th.
Check Out Our Latest Stock Report on Dolby Laboratories
Dolby Laboratories Trading Down 0.3%
Dolby Laboratories (NYSE:DLB – Get Free Report) last issued its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.72 by $0.06. The company had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%.The firm’s quarterly revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the company earned $0.71 EPS. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Equities research analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.
Dolby Laboratories Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.9%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories’s dividend payout ratio (DPR) is currently 48.35%.
Insider Activity at Dolby Laboratories
In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the completion of the transaction, the senior vice president owned 70,435 shares in the company, valued at $5,276,990.20. This trade represents a 9.04% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Kevin J. Yeaman sold 39,875 shares of the firm’s stock in a transaction that occurred on Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total value of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at $8,583,724.50. This represents a 25.79% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 99,366 shares of company stock valued at $7,293,963 in the last 90 days. 38.39% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Dolby Laboratories
Institutional investors have recently added to or reduced their stakes in the company. Bank of New York Mellon Corp boosted its holdings in shares of Dolby Laboratories by 18.3% in the 1st quarter. Bank of New York Mellon Corp now owns 5,709,193 shares of the electronics maker’s stock worth $458,505,000 after purchasing an additional 882,716 shares during the period. Norges Bank purchased a new position in shares of Dolby Laboratories in the 2nd quarter worth approximately $55,030,000. AQR Capital Management LLC boosted its holdings in shares of Dolby Laboratories by 51.8% in the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock worth $128,935,000 after purchasing an additional 592,282 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Dolby Laboratories by 7.1% in the 1st quarter. Vanguard Group Inc. now owns 7,535,722 shares of the electronics maker’s stock worth $605,194,000 after purchasing an additional 502,110 shares during the period. Finally, Jones Financial Companies Lllp boosted its holdings in shares of Dolby Laboratories by 241,160.1% in the 1st quarter. Jones Financial Companies Lllp now owns 429,443 shares of the electronics maker’s stock worth $36,975,000 after purchasing an additional 429,265 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More
- Five stocks we like better than Dolby Laboratories
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- Pros And Cons Of Monthly Dividend Stocks
- Starbucks Stock Slumps; This Competitor Shows Strength
- 3 Grocery Stocks That Are Proving They Are Still Essential
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.